AML-314: Post-Transplant Cyclophosphamide Reduces the Incidence of Acute Graft Versus Host Disease in AML/MDS Patients Who Receive Checkpoint Inhibitors After Allogeneic Stem Cell Transplant
2020 ◽
Vol 20
◽
pp. S201-S202
2017 ◽
Vol 23
(3)
◽
pp. S200-S201
◽
2016 ◽
Vol 22
(10)
◽
pp. 1829-1835
◽
2012 ◽
Vol 18
(2)
◽
pp. S367
2008 ◽
Vol 14
(2)
◽
pp. 132
2009 ◽
Vol 15
(1)
◽
pp. 59-61
◽
2011 ◽
Vol 17
(2)
◽
pp. S230
2017 ◽
Vol 23
(3)
◽
pp. S226